Kymera Therapeutics Inc.
KYMR
|
|
| |
|
| Trading Volume | 8,914 |
|
|
49.79 - 10.97 |
| Market Cap Full | $ 2.7B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 3.3% | 57.8% | 18.7% | -33.3% |
| Q2 | - | -23.4% | -22.4% | -53.5% |
| Q3 | - | 4.4% | -39.5% | 10.6% |
| Q4 | - | -19.3% | 87.6% | 14.7% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.3 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 28.8 | 30.3 | -5.9 | -15.4 | -5.6 | -5.9 | 53 | 4.4 | - | - | - | -13.9 |
| 2023 | |||||||||||
| 49.8 | -16.1 | -5.6 | 6.5 | -6.7 | -21.9 | -4.8 | -12.8 | -27.2 | -16 | 77.9 | 22.6 |
| 2022 | |||||||||||
| -36.6 | -1.3 | 6.4 | -25.9 | -54.5 | 38 | 11.9 | 28.3 | -23 | 39.4 | -4.5 | -13.9 |
| 2021 | |||||||||||
| -1.7 | -21.3 | -19 | 17.2 | 5.6 | 0.9 | 24.1 | 3.3 | -5.5 | 2 | -8.6 | 15.9 |
| 2020 | |||||||||||
| - | - | - | - | - | - | - | - | -0.9 | 13.9 | 31.7 | 30.8 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.7 | -0.7 | -0.3 | 0 |
| Q2 | -0.7 | -0.8 | -0.6 | 0 |
| Q3 | -0.9 | -0.8 | -0.6 | 0 |
| Q4 | 0 | -0.6 | -0.7 | 0 |
| A | -2.27 | -2.9 | -2.1 | -3.2 |